Javascript must be enabled to continue!
SU‐FF‐J‐30: Simultaneous Use of An Implanted Fiducial System and An Endorectal Balloon for the Treatment of Prostate Cancer
View through CrossRef
Purpose: To report on our initial experience of using an on‐line implanted fiducial system simultaneously with an endorectal balloon to treat patients with prostate cancer. Method and Materials: Patients had three fiducial seeds implanted in their prostate prior to radiotherapy treatment planning. Treatment was given in the prone position with an endorectal balloon inflated to 60 cc and a full bladder. Patients were initially positioned with the aid of lasers/tattoos and an immobilization cradle. Open‐field radiation electronic portal images were then taken in the treatment position and compared to reference images prior to each fraction of treatment. The intermarker distances (IMDs) between the three implanted seeds were examined to gain insight on prostate deformation and seed migration for this treatment strategy. The IMDs for the initial three fractions were averaged for each seed pair to serve as our references. For subsequent fractions, the differences in IMDs between measured and reference values were computed. Our data were also compared to similar previously reported studies. Results: We have analyzed the IMDs of 13 patients treated with implanted fiducials and an endorectal balloon. A total of 349 alignments were evaluable and thus, 1047 IMDs were calculated for this set of patients. The mean absolute IMD difference for all samples was 0.86±0.88 mm, while the largest single IMD difference was 8.9 mm. For individual patients, the ranges of mean absolute IMD differences for a given seed pair and corresponding standard deviations were 0.32–1.85 mm and 0.22–1.66 mm, respectively. The maximum absolute IMD difference for individual patients ranged from 1.2–8.9 mm. Conclusions: We have simultaneously implemented an on‐line implanted fiducial system and an endorectal balloon during prostate cancer radiotherapy. The degree of deformation of the prostate gland during treatment has been examined. This study may help predict the potential dosimetric consequences due to prostate motion/deformation.
Title: SU‐FF‐J‐30: Simultaneous Use of An Implanted Fiducial System and An Endorectal Balloon for the Treatment of Prostate Cancer
Description:
Purpose: To report on our initial experience of using an on‐line implanted fiducial system simultaneously with an endorectal balloon to treat patients with prostate cancer.
Method and Materials: Patients had three fiducial seeds implanted in their prostate prior to radiotherapy treatment planning.
Treatment was given in the prone position with an endorectal balloon inflated to 60 cc and a full bladder.
Patients were initially positioned with the aid of lasers/tattoos and an immobilization cradle.
Open‐field radiation electronic portal images were then taken in the treatment position and compared to reference images prior to each fraction of treatment.
The intermarker distances (IMDs) between the three implanted seeds were examined to gain insight on prostate deformation and seed migration for this treatment strategy.
The IMDs for the initial three fractions were averaged for each seed pair to serve as our references.
For subsequent fractions, the differences in IMDs between measured and reference values were computed.
Our data were also compared to similar previously reported studies.
Results: We have analyzed the IMDs of 13 patients treated with implanted fiducials and an endorectal balloon.
A total of 349 alignments were evaluable and thus, 1047 IMDs were calculated for this set of patients.
The mean absolute IMD difference for all samples was 0.
86±0.
88 mm, while the largest single IMD difference was 8.
9 mm.
For individual patients, the ranges of mean absolute IMD differences for a given seed pair and corresponding standard deviations were 0.
32–1.
85 mm and 0.
22–1.
66 mm, respectively.
The maximum absolute IMD difference for individual patients ranged from 1.
2–8.
9 mm.
Conclusions: We have simultaneously implemented an on‐line implanted fiducial system and an endorectal balloon during prostate cancer radiotherapy.
The degree of deformation of the prostate gland during treatment has been examined.
This study may help predict the potential dosimetric consequences due to prostate motion/deformation.
Related Results
Eficacia, seguridad y eficiencia de la radioterapia corporal estereotáctica aplicada con marcadores de referencia en oncología
Eficacia, seguridad y eficiencia de la radioterapia corporal estereotáctica aplicada con marcadores de referencia en oncología
Introduction
Stereotactic body radiotherapy (SBRT) is a technology that involves delivering high doses of radiation, in few sessios and with high precision, to a specific tumor loc...
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract
Background: Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. It is the third most common cancer in men in Algeri...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract
BACKGROUND: Multiple steps and factors are involved in prostate carcinogenesis and tumor progression. The early studies have found that tumor-associated mac...
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group
ImportanceAdvocates for removing the cancer label from grade group 1 (GG1) prostate cancer detected on biopsy primarily base their argument on the observation that when only GG1 is...
Understanding Barriers to Engagement With a Prostate Cancer Research and Genetic Risk Service Among UK Men of Black African or Black Caribbean Ancestry
Understanding Barriers to Engagement With a Prostate Cancer Research and Genetic Risk Service Among UK Men of Black African or Black Caribbean Ancestry
ABSTRACT
Introduction
Prostate cancer is the second most common cancer worldwide, and there is no national prostate cance...
Study on Early Prostate Cancer Antigen (EPCA) and existent risk factors of prostate cancer, Sudan: A case-control study
Study on Early Prostate Cancer Antigen (EPCA) and existent risk factors of prostate cancer, Sudan: A case-control study
Background: Early prostate cancer antigen (EPCA), a nuclear matrix protein, has recently been recommended as a hopeful biomarker for early prostate carcinogenesis. Objectives: To e...
Holmium laser enucleation of the prostate versus bipolar transurethral enucleation of the prostate in management of benign prostatic hyperplasia: A randomized controlled trial
Holmium laser enucleation of the prostate versus bipolar transurethral enucleation of the prostate in management of benign prostatic hyperplasia: A randomized controlled trial
Objective
To evaluate the safety, efficacy and cost‐effectiveness of holmium enucleation of the prostate and bipolar transurethral enucleation of the prostate.
...

